Cargando…

Peripheral platelet/lymphocyte ratio predicts lymph node metastasis and acts as a superior prognostic factor for cervical cancer when combined with neutrophil: Lymphocyte

Inflammation-based indicators such as neutrophil/lymphocyte ratio (NLR), derived NLR (dNLR), and platelet/lymphocyte ratio (PLR) have been reported to possess significant predictive value for several types of cancer. We investigated the predictive value of these 3 biomarkers on lymph node metastasis...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Liang, Zhang, Fang, Sheng, Xiu-gui, Zhang, Shi-qian, Chen, Yue-ting, Liu, Bo-wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985304/
https://www.ncbi.nlm.nih.gov/pubmed/27512849
http://dx.doi.org/10.1097/MD.0000000000004381
_version_ 1782448039830487040
author Chen, Liang
Zhang, Fang
Sheng, Xiu-gui
Zhang, Shi-qian
Chen, Yue-ting
Liu, Bo-wen
author_facet Chen, Liang
Zhang, Fang
Sheng, Xiu-gui
Zhang, Shi-qian
Chen, Yue-ting
Liu, Bo-wen
author_sort Chen, Liang
collection PubMed
description Inflammation-based indicators such as neutrophil/lymphocyte ratio (NLR), derived NLR (dNLR), and platelet/lymphocyte ratio (PLR) have been reported to possess significant predictive value for several types of cancer. We investigated the predictive value of these 3 biomarkers on lymph node metastasis (LNM) and clinical outcome in patients with stage Ib1–IIa cervical cancer undergoing radical surgery. A total of 407 patients with FIGO stage Ib1–IIa cervical cancer, who underwent radical surgery between January 2006 and December 2009 at the Department of Gynecological and Oncology of Shandong Cancer Hospital Affiliated to Shandong University were recruited. Binary logistic regression analysis was performed to determine the relationship between PLR, NLR, dNLR, and LNM. Multivariate Cox regression analysis was performed to determine the association between the 3 indices and recurrence-free survival (RFS) and overall survival (OS). Optimal cut-off values for the 3 indices were determined by applying receiver operating curve (ROC) analysis. Univariate and binary logistic regression analyses both indicate that PLR was significantly associated with increased LNM (P < 0.05). In the multivariate survival analysis, increased preoperative PLR and NLR were significantly associated with reduced RFS (P = 0.001 and P = 0.002, respectively), whereas a combination of both PLR and NLR revealed a more significant association with reduced RFS (P < 0.001). Furthermore, increased preoperative PLR and NLR were significantly associated with reduced OS (P = 0.007 and P = 0.009, respectively), whereas the combined use of PLR and NLR revealed a more significant association with reduced OS (P = 0.003). PLR is an independent risk factor for increased LNM and clinical outcome in patients with stage Ib1–IIa cervical cancer. A combination of PLR and NLR may enable better risk stratification for predicting survival.
format Online
Article
Text
id pubmed-4985304
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-49853042016-08-26 Peripheral platelet/lymphocyte ratio predicts lymph node metastasis and acts as a superior prognostic factor for cervical cancer when combined with neutrophil: Lymphocyte Chen, Liang Zhang, Fang Sheng, Xiu-gui Zhang, Shi-qian Chen, Yue-ting Liu, Bo-wen Medicine (Baltimore) 5700 Inflammation-based indicators such as neutrophil/lymphocyte ratio (NLR), derived NLR (dNLR), and platelet/lymphocyte ratio (PLR) have been reported to possess significant predictive value for several types of cancer. We investigated the predictive value of these 3 biomarkers on lymph node metastasis (LNM) and clinical outcome in patients with stage Ib1–IIa cervical cancer undergoing radical surgery. A total of 407 patients with FIGO stage Ib1–IIa cervical cancer, who underwent radical surgery between January 2006 and December 2009 at the Department of Gynecological and Oncology of Shandong Cancer Hospital Affiliated to Shandong University were recruited. Binary logistic regression analysis was performed to determine the relationship between PLR, NLR, dNLR, and LNM. Multivariate Cox regression analysis was performed to determine the association between the 3 indices and recurrence-free survival (RFS) and overall survival (OS). Optimal cut-off values for the 3 indices were determined by applying receiver operating curve (ROC) analysis. Univariate and binary logistic regression analyses both indicate that PLR was significantly associated with increased LNM (P < 0.05). In the multivariate survival analysis, increased preoperative PLR and NLR were significantly associated with reduced RFS (P = 0.001 and P = 0.002, respectively), whereas a combination of both PLR and NLR revealed a more significant association with reduced RFS (P < 0.001). Furthermore, increased preoperative PLR and NLR were significantly associated with reduced OS (P = 0.007 and P = 0.009, respectively), whereas the combined use of PLR and NLR revealed a more significant association with reduced OS (P = 0.003). PLR is an independent risk factor for increased LNM and clinical outcome in patients with stage Ib1–IIa cervical cancer. A combination of PLR and NLR may enable better risk stratification for predicting survival. Wolters Kluwer Health 2016-08-12 /pmc/articles/PMC4985304/ /pubmed/27512849 http://dx.doi.org/10.1097/MD.0000000000004381 Text en Copyright © 2016 the Author(s). Published by Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 5700
Chen, Liang
Zhang, Fang
Sheng, Xiu-gui
Zhang, Shi-qian
Chen, Yue-ting
Liu, Bo-wen
Peripheral platelet/lymphocyte ratio predicts lymph node metastasis and acts as a superior prognostic factor for cervical cancer when combined with neutrophil: Lymphocyte
title Peripheral platelet/lymphocyte ratio predicts lymph node metastasis and acts as a superior prognostic factor for cervical cancer when combined with neutrophil: Lymphocyte
title_full Peripheral platelet/lymphocyte ratio predicts lymph node metastasis and acts as a superior prognostic factor for cervical cancer when combined with neutrophil: Lymphocyte
title_fullStr Peripheral platelet/lymphocyte ratio predicts lymph node metastasis and acts as a superior prognostic factor for cervical cancer when combined with neutrophil: Lymphocyte
title_full_unstemmed Peripheral platelet/lymphocyte ratio predicts lymph node metastasis and acts as a superior prognostic factor for cervical cancer when combined with neutrophil: Lymphocyte
title_short Peripheral platelet/lymphocyte ratio predicts lymph node metastasis and acts as a superior prognostic factor for cervical cancer when combined with neutrophil: Lymphocyte
title_sort peripheral platelet/lymphocyte ratio predicts lymph node metastasis and acts as a superior prognostic factor for cervical cancer when combined with neutrophil: lymphocyte
topic 5700
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985304/
https://www.ncbi.nlm.nih.gov/pubmed/27512849
http://dx.doi.org/10.1097/MD.0000000000004381
work_keys_str_mv AT chenliang peripheralplateletlymphocyteratiopredictslymphnodemetastasisandactsasasuperiorprognosticfactorforcervicalcancerwhencombinedwithneutrophillymphocyte
AT zhangfang peripheralplateletlymphocyteratiopredictslymphnodemetastasisandactsasasuperiorprognosticfactorforcervicalcancerwhencombinedwithneutrophillymphocyte
AT shengxiugui peripheralplateletlymphocyteratiopredictslymphnodemetastasisandactsasasuperiorprognosticfactorforcervicalcancerwhencombinedwithneutrophillymphocyte
AT zhangshiqian peripheralplateletlymphocyteratiopredictslymphnodemetastasisandactsasasuperiorprognosticfactorforcervicalcancerwhencombinedwithneutrophillymphocyte
AT chenyueting peripheralplateletlymphocyteratiopredictslymphnodemetastasisandactsasasuperiorprognosticfactorforcervicalcancerwhencombinedwithneutrophillymphocyte
AT liubowen peripheralplateletlymphocyteratiopredictslymphnodemetastasisandactsasasuperiorprognosticfactorforcervicalcancerwhencombinedwithneutrophillymphocyte